Which item summarizes findings from nonclinical studies and clinical trials relevant to the trial?

• A. Description of the trial protocol summary
• B. A summary of findings from nonclinical studies and clinical trials relevant to the trial
• C. The description of the population to be studied
• D. References to literature and data that are relevant to the trial

Answer: (B)

Summarizing what has been learned from nonclinical and prior clinical studies that are relevant to the trial provides the essential rationale for why this study is needed. This synthesis includes safety, pharmacology, toxicology, and any signals of efficacy or lack thereof from earlier work, and it directly informs the trial’s design, risk–benefit assessment, and dosing considerations. By pulling together these findings, the protocol shows reviewers and investigators the scientific justification for proceeding, ensuring the study is grounded in established evidence rather than starting from scratch.

Describing the protocol itself would outline how the study will be run, not why it’s being done. Describing the population to be studied covers who will participate, not the supporting evidence. Merely listing literature references provides sources without integrating what those findings mean for the trial’s rationale.